Lv3
360 积分 2021-09-28 加入
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
4小时前
待确认
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study
1个月前
已完结
Proteomic and phosphoproteomic landscape of localized prostate cancer unveils distinct molecular subtypes and insights into precision therapeutics
1个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
1个月前
已完结
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate
2个月前
已完结
Development and Validation of a Contrast-Enhanced US VI-RADS for Evaluating Muscle Invasion in Bladder Cancer
2个月前
已完结
Genomic profiling and immune phenotyping of neuroendocrine bladder cancer
2个月前
已完结
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
2个月前
已完结
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
2个月前
已完结
Renal Cell Carcinoma
2个月前
已完结
皖公网安备34019202002308
